We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Prevalence of Glucose Intolerance and Risk Factors in Ethiopian Immigrants in Israel; Follow-up Study.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01402362
Recruitment Status : Unknown
Verified June 2011 by Hillel Yaffe Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : July 26, 2011
Last Update Posted : July 26, 2011
Information provided by:
Hillel Yaffe Medical Center

Brief Summary:
High risk population: Screening for impaired glucose tolerance.

Condition or disease
Diabetes Mellitus Glucose Intolerance

Study Type : Observational
Estimated Enrollment : 550 participants
Observational Model: Cohort
Time Perspective: Prospective
Study Start Date : September 2011

Ethiopians participating in previous study, year 2000

Primary Outcome Measures :
  1. Percent of patients with Diabetes Mellitus or impaired glucose tolerance [ Time Frame: Day 1 of study ]

Secondary Outcome Measures :
  1. Prevalence of hypertension and hyperlipidemia [ Time Frame: Day 1 of study ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   25 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Ethiopian immigrants to Israel living in Hadera.

Inclusion Criteria:

  • Participation in the year 2000 study
  • Signature of Informed Consent Form

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01402362

Contact: Anat Jaffe, MD PhD +97246304748 Jaffe@hy.health.gov.il

Diabetes and Endocrinology Unit, Hillel Yaffe MC, POB169 Not yet recruiting
Hadera, Israel, 38100
Contact: Anat Jaffe, MD PhD    +97246304748    jaffe@hy.health.gov.il   
Sub-Investigator: Liana Tripto, MD         
Principal Investigator: Anat Jaffe, MD PhD         
Sponsors and Collaborators
Hillel Yaffe Medical Center

Responsible Party: Diabetes and Endocrinology Unit, Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier: NCT01402362     History of Changes
Other Study ID Numbers: 56-2011
First Posted: July 26, 2011    Key Record Dates
Last Update Posted: July 26, 2011
Last Verified: June 2011

Keywords provided by Hillel Yaffe Medical Center:
Diabetes Mellitus
Glucose tolerance
Included in the year 2000 study

Additional relevant MeSH terms:
Diabetes Mellitus
Glucose Intolerance
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases